Correlation Between Terns Pharmaceuticals and Gossamer Bio
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Gossamer Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Gossamer Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Gossamer Bio, you can compare the effects of market volatilities on Terns Pharmaceuticals and Gossamer Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Gossamer Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Gossamer Bio.
Diversification Opportunities for Terns Pharmaceuticals and Gossamer Bio
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Terns and Gossamer is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Gossamer Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gossamer Bio and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Gossamer Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gossamer Bio has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Gossamer Bio go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Gossamer Bio
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 1.33 times more return on investment than Gossamer Bio. However, Terns Pharmaceuticals is 1.33 times more volatile than Gossamer Bio. It trades about -0.16 of its potential returns per unit of risk. Gossamer Bio is currently generating about -0.32 per unit of risk. If you would invest 710.00 in Terns Pharmaceuticals on September 4, 2024 and sell it today you would lose (95.00) from holding Terns Pharmaceuticals or give up 13.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Gossamer Bio
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Gossamer Bio |
Terns Pharmaceuticals and Gossamer Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Gossamer Bio
The main advantage of trading using opposite Terns Pharmaceuticals and Gossamer Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Gossamer Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will offset losses from the drop in Gossamer Bio's long position.| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
| Gossamer Bio vs. Biomea Fusion | Gossamer Bio vs. Stoke Therapeutics | Gossamer Bio vs. Akero Therapeutics | Gossamer Bio vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |